H1 radioligand displacement in intact U373 MG cells
Biochemical assay · Intact human U373 MG astrocytoma cells, with or without histamine pretreatment [1]
Azelastine displaced [3H]mepyramine with a one-site fit. Histamine pretreatment did not significantly change its binding parameters. This assay measures receptor binding; it does not directly measure clinical sedation or functional antagonism.
| Endpoint | Reported result | Reference |
|---|---|---|
| Displacement of 5 nM [3H]mepyramine in cells without histamine pretreatment | pIC50 7.27 ± 0.07 (mean ± S.E.M.; n=4) | [1] |
| Displacement of 5 nM [3H]mepyramine after histamine pretreatment | pIC50 7.08 ± 0.06 (mean ± S.E.M.; n=4); no significant change versus control | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Various azelastine concentrations in a displacement series; radioligand 5 nM [3H]mepyramine.
- Exposure duration
- 120 min binding incubation at 4°C; comparison cells pretreated with 0.1 mM histamine for 30 min at 37°C and washed.
- Method
- Intact-cell competitive radioligand binding in normal HEPES buffer.
- Reported limits
- Individual azelastine concentrations are plotted, not tabulated. Drug stock solvent is not specified in the shared methods; normal HEPES is the assay medium.
Methods and source locations
Compound reported in the paper: Azelastine hydrochloride; Compound label in the paper: Azelastine
Evidence for the reported hydrochloride material; stereochemical composition was not specified. No validation of an Adooq lot or equivalence of formulations is implied.
pp. 67–70 Materials and Methods and Results; Table 1 (p. 71), azelastine row; Fig. 3d (p. 72); Figs. 1–2 shared controls
Displacement of 5 nM [3H]mepyramine in cells without histamine pretreatment: Intact-cell radioligand competition; pIC50 = −log[IC50 (M)]; quadruplicate determinations. — Table 1 (p. 71), azelastine/control row; pp. 68 Data analyses; Fig. 3d/caption (p. 72)
Displacement of 5 nM [3H]mepyramine after histamine pretreatment: One-site fitting of competition curves; shared data analysis uses Student’s t test with P<0.05 threshold. — Table 1 (p. 71), azelastine/histamine-pretreated row; p. 70 Results; Fig. 3d/caption (p. 72)